Usefulness of immunological detection of the human telomerase reverse transcriptase

Annalisa Volpi, Sara Bravaccini, Laura Medri, Serenella Cerasoli, Michele Gaudio, Dino Amadori

Research output: Contribution to journalArticle

Abstract

Objective: Recent years have seen a considerable wealth of studies conducted on the potential usefulness of telomerase determination in diagnosis, prognosis and targeted cancer therapy. The frequently used Telomeric Repeat Amplification Protocol assay suffers from some drawbacks, the most important being the rate of false positives. In situ analysis using well characterised antibodies directed against the human telomerase reverse transcriptase (hTERT) would therefore appear to be important to morphologically identify the nature of telomerase positive cells. Methods: We performed immunostaining in a series of cultured cells and in normal, preneoplastic and tumour tissues from different organs using a monoclonal antibody directed against the catalytic subunit of telomerase. Results: Immunoreactivity was not observed in perennial cells of terminally differentiated cardiac and skeletal muscular tissues or in small pyramidal cells of the cerebral cortex. Conversely, it was found in other normal somatic tissues as well as in precancerous lesions and in all tumour histotypes. Conclusions: Immunohistochemistry with a well characterised hTERT-specific monoclonal antibody permitted the identification of hTERT immunopositive cells in normal somatic tissues. Whether hTERT protein detected by immunostaining with hTERT-specific Tel 3 36-10 antibody is actually the degraded form of the protein that retains hTERT antigenicity but not enzymatic function, or whether it represents the real, potentially functional catalytic subunit of the enzyme, immunohistochemistry would not seem to represent a useful tool to investigate the role of telomerase and the mechanisms involved in its regulation.

Original languageEnglish
Pages (from-to)347-353
Number of pages7
JournalCellular Oncology
Volume27
Issue number5-6
Publication statusPublished - 2005

Fingerprint

Telomerase
Immunohistochemistry
Monoclonal Antibodies
Neoplasms
Antibodies
Pyramidal Cells
Cerebral Cortex
human TERT protein
Cultured Cells
Catalytic Domain
Proteins
Enzymes
Therapeutics

Keywords

  • hTERT immunohistochemical expression
  • Normal and tumour tissue
  • Telomerase

ASJC Scopus subject areas

  • Cell Biology
  • Pathology and Forensic Medicine
  • Oncology

Cite this

Volpi, A., Bravaccini, S., Medri, L., Cerasoli, S., Gaudio, M., & Amadori, D. (2005). Usefulness of immunological detection of the human telomerase reverse transcriptase. Cellular Oncology, 27(5-6), 347-353.

Usefulness of immunological detection of the human telomerase reverse transcriptase. / Volpi, Annalisa; Bravaccini, Sara; Medri, Laura; Cerasoli, Serenella; Gaudio, Michele; Amadori, Dino.

In: Cellular Oncology, Vol. 27, No. 5-6, 2005, p. 347-353.

Research output: Contribution to journalArticle

Volpi, A, Bravaccini, S, Medri, L, Cerasoli, S, Gaudio, M & Amadori, D 2005, 'Usefulness of immunological detection of the human telomerase reverse transcriptase', Cellular Oncology, vol. 27, no. 5-6, pp. 347-353.
Volpi A, Bravaccini S, Medri L, Cerasoli S, Gaudio M, Amadori D. Usefulness of immunological detection of the human telomerase reverse transcriptase. Cellular Oncology. 2005;27(5-6):347-353.
Volpi, Annalisa ; Bravaccini, Sara ; Medri, Laura ; Cerasoli, Serenella ; Gaudio, Michele ; Amadori, Dino. / Usefulness of immunological detection of the human telomerase reverse transcriptase. In: Cellular Oncology. 2005 ; Vol. 27, No. 5-6. pp. 347-353.
@article{ef33aefce4cf453f8ed368f45148a6aa,
title = "Usefulness of immunological detection of the human telomerase reverse transcriptase",
abstract = "Objective: Recent years have seen a considerable wealth of studies conducted on the potential usefulness of telomerase determination in diagnosis, prognosis and targeted cancer therapy. The frequently used Telomeric Repeat Amplification Protocol assay suffers from some drawbacks, the most important being the rate of false positives. In situ analysis using well characterised antibodies directed against the human telomerase reverse transcriptase (hTERT) would therefore appear to be important to morphologically identify the nature of telomerase positive cells. Methods: We performed immunostaining in a series of cultured cells and in normal, preneoplastic and tumour tissues from different organs using a monoclonal antibody directed against the catalytic subunit of telomerase. Results: Immunoreactivity was not observed in perennial cells of terminally differentiated cardiac and skeletal muscular tissues or in small pyramidal cells of the cerebral cortex. Conversely, it was found in other normal somatic tissues as well as in precancerous lesions and in all tumour histotypes. Conclusions: Immunohistochemistry with a well characterised hTERT-specific monoclonal antibody permitted the identification of hTERT immunopositive cells in normal somatic tissues. Whether hTERT protein detected by immunostaining with hTERT-specific Tel 3 36-10 antibody is actually the degraded form of the protein that retains hTERT antigenicity but not enzymatic function, or whether it represents the real, potentially functional catalytic subunit of the enzyme, immunohistochemistry would not seem to represent a useful tool to investigate the role of telomerase and the mechanisms involved in its regulation.",
keywords = "hTERT immunohistochemical expression, Normal and tumour tissue, Telomerase",
author = "Annalisa Volpi and Sara Bravaccini and Laura Medri and Serenella Cerasoli and Michele Gaudio and Dino Amadori",
year = "2005",
language = "English",
volume = "27",
pages = "347--353",
journal = "Cellular oncology (Dordrecht)",
issn = "2211-3428",
publisher = "IOS Press",
number = "5-6",

}

TY - JOUR

T1 - Usefulness of immunological detection of the human telomerase reverse transcriptase

AU - Volpi, Annalisa

AU - Bravaccini, Sara

AU - Medri, Laura

AU - Cerasoli, Serenella

AU - Gaudio, Michele

AU - Amadori, Dino

PY - 2005

Y1 - 2005

N2 - Objective: Recent years have seen a considerable wealth of studies conducted on the potential usefulness of telomerase determination in diagnosis, prognosis and targeted cancer therapy. The frequently used Telomeric Repeat Amplification Protocol assay suffers from some drawbacks, the most important being the rate of false positives. In situ analysis using well characterised antibodies directed against the human telomerase reverse transcriptase (hTERT) would therefore appear to be important to morphologically identify the nature of telomerase positive cells. Methods: We performed immunostaining in a series of cultured cells and in normal, preneoplastic and tumour tissues from different organs using a monoclonal antibody directed against the catalytic subunit of telomerase. Results: Immunoreactivity was not observed in perennial cells of terminally differentiated cardiac and skeletal muscular tissues or in small pyramidal cells of the cerebral cortex. Conversely, it was found in other normal somatic tissues as well as in precancerous lesions and in all tumour histotypes. Conclusions: Immunohistochemistry with a well characterised hTERT-specific monoclonal antibody permitted the identification of hTERT immunopositive cells in normal somatic tissues. Whether hTERT protein detected by immunostaining with hTERT-specific Tel 3 36-10 antibody is actually the degraded form of the protein that retains hTERT antigenicity but not enzymatic function, or whether it represents the real, potentially functional catalytic subunit of the enzyme, immunohistochemistry would not seem to represent a useful tool to investigate the role of telomerase and the mechanisms involved in its regulation.

AB - Objective: Recent years have seen a considerable wealth of studies conducted on the potential usefulness of telomerase determination in diagnosis, prognosis and targeted cancer therapy. The frequently used Telomeric Repeat Amplification Protocol assay suffers from some drawbacks, the most important being the rate of false positives. In situ analysis using well characterised antibodies directed against the human telomerase reverse transcriptase (hTERT) would therefore appear to be important to morphologically identify the nature of telomerase positive cells. Methods: We performed immunostaining in a series of cultured cells and in normal, preneoplastic and tumour tissues from different organs using a monoclonal antibody directed against the catalytic subunit of telomerase. Results: Immunoreactivity was not observed in perennial cells of terminally differentiated cardiac and skeletal muscular tissues or in small pyramidal cells of the cerebral cortex. Conversely, it was found in other normal somatic tissues as well as in precancerous lesions and in all tumour histotypes. Conclusions: Immunohistochemistry with a well characterised hTERT-specific monoclonal antibody permitted the identification of hTERT immunopositive cells in normal somatic tissues. Whether hTERT protein detected by immunostaining with hTERT-specific Tel 3 36-10 antibody is actually the degraded form of the protein that retains hTERT antigenicity but not enzymatic function, or whether it represents the real, potentially functional catalytic subunit of the enzyme, immunohistochemistry would not seem to represent a useful tool to investigate the role of telomerase and the mechanisms involved in its regulation.

KW - hTERT immunohistochemical expression

KW - Normal and tumour tissue

KW - Telomerase

UR - http://www.scopus.com/inward/record.url?scp=29244489594&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29244489594&partnerID=8YFLogxK

M3 - Article

C2 - 16373967

AN - SCOPUS:29244489594

VL - 27

SP - 347

EP - 353

JO - Cellular oncology (Dordrecht)

JF - Cellular oncology (Dordrecht)

SN - 2211-3428

IS - 5-6

ER -